GLP-1 Pipeline Update: February 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
Clinical trial standards The SURMOUNT clinical trial program for tirzepatide enrolled over 5,000 participants across multiple countries
You should stop using Wegovy 2 months before you plan to become pregnant are breastfeeding or plan to breastfeed
Can novel weight loss drugs change the healthcare landscape
That's when I spoke with my doctor about my concerns, and discussed other options
Is niacinamide better than B12